Horn of Africa faces most ‘catastrophic’ food insecurity in decades, warns WHO

The World Health Organization (WHO) warned on Tuesday that the Greater Horn of Africa is experiencing one of the worst hunger crises of the last 70 years. 

More than 37 million people are facing acute hunger, with approximately seven million children under the age of five acutely malnourished in the region. 

While finding food and safe water is the absolute priority, WHO said that ensuring a strong health emergency response is needed to avert preventable disease and deaths. 

The UN agency is calling for $123.7 million to respond to rising health needs and prevent a food crisis from turning into a health crisis. 

“The situation is already catastrophic, and we need to act now,” said Ibrahima Soce Fall, WHO Assistant Director General for Emergencies Response. “We cannot continue in this underfunding crisis”.

Severe drought 

The Horn of Africa includes Djibouti, Somalia, Sudan, South Sudan, Ethiopia, Uganda, and Kenya. 

Climate change, conflict, rising food prices and the COVID-19 pandemic have compounded one of the worst droughts in the region in recent decades, according to the WHO appeal,

“There are now four seasons where the rain didn’t come as predicted and a fifth season is estimated to also fail. Places where there is drought the problem keeps worsening and worsening,” said WHO Incident Manager Sophie Maes. 

“In other places like South Sudan, there have been three years of consecutive flooding with almost 40 per cent of the country being flooded. And we are looking at something that is going to get worse in the near future.” 

Hunger crisis

Over 37 million people in the region are projected to reach the third level of the Integrated Food Security Phase Classification scale (IPC3) and higher in the coming months. 

This means that the population is in crisis, and only marginally able to meet minimum food needs by depleting essential livelihood assets or through crisis-coping strategies.

The effects of drought are particularly severe in eastern and southern Ethiopia, eastern and northern Kenya, and southern and central Somalia. 

Food insecurity in South Sudan has reached the most extreme levels since independence in 2011, with 8.3 million people comprising 75 per cent of the population facing severe food insecurity.

Cost of inaction

Acute malnutrition leads to increased migration as populations move in search of food and pasture, according to WHO.

And disruptions often result in deteriorating hygiene and sanitation as outbreaks of infectious diseases, like cholera, measles, and malaria, are already on the rise. 

Moreover, weak vaccination coverage and health services with insufficient resources could see a widespread increase in the number of disease outbreaks in country and across borders.

Care for severely malnourished children with medical complications will be severely impacted and result in high child mortality rates. 

Disruptions in access to health care can further increase morbidity and mortality, as emergency conditions force populations to modify their health-seeking behaviour and prioritize access to life-saving resources such as food and water.

Source: United Nations

President to lead talks at High Level South Africa – Botswana Business Roundtable

President Cyril Ramaphosa will on Thursday, 04 August 2022, embark on a working visit to the Republic of Botswana to lead talks at the High Level South Africa – Botswana Business Roundtable. 

President will travel to Gaborone at the invitation of the His Excellency Dr.Eric Mokgweetsi Masisi, President of the Republic of Botswana. 

The High Level South Africa – Botswana Business Roundtable happens at the backdrop of the fifth session of the South Africa – Botswana Bi-National Commission (BNC) which took place on 22 April 2022 in Tshwane. 

The two neighboring countries are this year marking 28 years of diplomatic and bilateral cooperation which spans across trade and investment, energy, agriculture, tourism, youth and sport, infrastructure development, culture, mining, defence and security, immigration, environmental conservation and management, transport as well as information and communication technologies.

Preceded by the South Africa – Botswana Business Forum scheduled on 03 August 2022, which draws government and business leaders from both countries, the business forum will among others identify a package of concrete actions to create a conducive environment to strengthen business to business linkages; support the implementation of Southern African Customs Union (SACU) regional value chains and the African Continental Free Trade Area (AfCFTA). 

Over the two-day South Africa – Botswana Business Forum, 22 South African businesses from a wide range of sectors will form part of the trade expo of the businesses operating in both countries at the Gaborone International Convention Centre. South Africa is Botswana’s number one source of imports, whilst Botswana ranked as South Africa’s 7th largest export market. South Africa’s exports to Botswana were R64.4 billion in 2021, exports to Botswana grew by 2.53 percent or R13.4 billion over the last five years. 

President Ramaphosa will be accompanied by Minister of International Relations and Cooperation Dr Naledi Pandor and Minister of Trade, Industry and Competition Ebrahim Patel. 

Source: The Presidency Republic of South Africa

‫شركة Bybit سريعة النمو لتبادل العملات المشفرة تطلق منتج Shark Fin المنظّم

مدينة فيكتوريا، سيشيل، – 1 أغسطس 2022 – أطلقت شركة Bybit، ثالث أكثر منصة لتبادل العملات الرقمية زيارةً في العالم، منتجًا منظمًا جديدًا وهو Bybit Shark Fin لجميع المستخدمين في 14 يوليو 2022.

ويُعد Bybit Shark Fin منتجًا منظّمًا منخفض المخاطر مع رأس مال مضمون يوفر حماية أفضل لرأس المال للمستخدمين مع إمكانية تحقيق أرباح عالية في الوقت ذاته. حيث يمكن للمستخدمين إيداع أموالهم في المنتج والحصول على عائد استنادًا إلى مستوى أداء استراتيجية التداول. وتستخدم الاستراتيجية الأساسية في التداول خيارات الاستدعاء صعودًا ونزولاً لتوليد العوائد.

وهذا يعني أن مستخدمي منصة Bybit سريعة النمو لخدمات التداول، والتي تقوم بمعالجة ما يصل إلى 100 ألف معاملة في الثانية، يمكنهم إيداع عملات مستقرة، مثل USDT أو USDC، لكسب عوائد جذابة مع مخاطر أقل.

ويتم احتساب العائد النهائي حسب سعر تسوية الأصل الأساسي عند انتهاء صلاحية الخطة، مقارنةً بنطاق السعر المحدد مسبقًا. وهناك خطط بفترات زمنية للاختيار من بينها والتي تتراوح من سبعة إلى 21 يومًا.

ومع نهاية الفترة الزمنية للخطة المحددة، إذا كان السعر النهائي يقع ضمن النطاق السعري المحدد مسبقًا، فيمكن للمستخدمين الحصول على أقصى عائد يصل إلى 20%. كما أنه إذا استقر السعر على أقل أو أعلى من النطاق السعري، فيمكن للمستخدمين الحصول على عوائد بما يصل إلى 3% أو 10% على التوالي.

ويتضمن المنتج استراتيجيات صعودية أو تنازلية تتنبأ بما إذا كان سعر الأصل الأساسي سيرتفع أم ينخفض. لذلك، في حالة تقلب أسعار السوق بسرعة في أي من الاتجاهين، سواء صعودًا أو هبوطًا ضمن نطاق مؤشر أسعار المنتج المحدد، يكون لدى المشتركين فرصة أفضل لتحقيق أفضل عائد.

وفي إطار بيئة خالية من المخاطر، يمكن للعديد من الأشخاص امتلاك عملات مستقرة، والسعي نحو تحقيق عائد منخفض المخاطر لرأس مالهم. بالإضافة إلى ذلك، تعد Bybit، مع التزامها بمستوى أمان وصندوق تأمين وخدمة عملاء تعمل على مدار الساعة وطوال أيام الأسبوع بمستوى عالمي وبلغات متعددة، خيارًا شائعًا للمستثمرين الذين يتطلعون إلى تحقيق عوائد على عملاتهم المستقرة.

وقد صرَّح “بن زو”، الشريك المؤسس والرئيس التنفيذي لشركة Bybit قائلاً “لدى شركة Bybit مجموعة واسعة من المنتجات التي تناسب كل مستثمر، ويُعد منتج Bybit Shark Fin إضافةً رائعةً إلى مجموعة منتجاتنا المتخصصة من المنتجات المدِّرة للعائد”. “ويُعد منتج التداول هذا مثالي للمستخدمين الذين يبحثون عن استثمار بسيط ومنخفض المخاطر يتم تسويته على فترات منتظمة.”

وجدير بالذكر، فإن منتج Bybit Shark Fin يُعد أحدث إضافة إلى مجموعة Bybit Earn، وهي منصة لإدارة الأصول تتضمن ميزات مجمع تعدين الأصول والسيولة المزدوجة من Bybit. وبالنسبة لمنتجاتها الشاملة للتداول، أنشأت Bybit منتجات التداول بالهامش القائم على أساس المخاطر، مما يعني أن نظام Bybit يمكن أن يحقق الأرباح من المراكز الفائزة لدعم المركز في ظل تقلبات السوق لتحقيق أقصى قدر من كفاءة رأس المال.

نبذة Bybit

Bybit هي منصة متخصصة في تداول العملات المشفرة تم إنشاؤها في مارس 2018 توفر منصة احترافية حيث يمكن لمتداولي العملات المشفرة من خلالها العثور على أداة مطابقة فائقة السرعة مع توفير خدمة عملاء ممتازة وخدمة دعم مجتمع المتداولين بعدة لغات. وتفخر Bybit بكونها شريك لفِرق سباقات Formula One، وOracle Red Bull Racing، وفِرق الألعاب الإلكترونية، مثل NAVI، وAstralis، وAlliance، وVirtus.pro، وMade in Brazil (MIBR) وOracle Red Bull Racing Esports، وفرق كرة القدم  مثل Borussia Dortmund وAvispa Fukuoka.

لمزيد من المعلومات، يُرجى زيارة: https://www.bybit.com/

للاطلاع على التحديثات، يُرجى متابعة صفحتنا على منصات وسائل التواصل الاجتماعي

https://discord.com/invite/bybit
https://www.facebook.com/Bybit
https://www.instagram.com/bybit_official/
https://www.linkedin.com/company/bybitexchange/
https://www.reddit.com/r/Bybit/
https://t.me/BybitEnglish
https://www.tiktok.com/@bybit_official
https://twitter.com/Bybit_Official
https://www.youtube.com/c/Bybit

للاستفسارات الإعلامية، يُرجى التواصل عبر: press@bybit.com

Vantage partners UNHCR for global fundraising activity for refugees, matches donations dollar-for-dollar.

SINGAPORE, Aug. 1, 2022 /PRNewswire/ — Vantage, an international multi-asset broker, is pleased to announce that it is launching a month-long donation drive in support of UNHCR, the UN Refugee Agency, to help refugees and internally displaced persons worldwide.

Vantage partners UNHCR for global fundraising activity for refugees, matches donations dollar-for-dollar.

Vantage will be matching all donations from both new and existing clients, dollar for dollar, to support humanitarian efforts undertaken by UNHCR. The donation drive will run for one month until 30 August and may be extended based on client feedback.

UNHCR is a global organisation that has spent the last 70 years dedicated to saving lives, protecting rights and building a better future for refugees. Vantage and UNHCR jointly believe that everyone has the right to seek asylum and find safe refuge.

According to UNHCR, the number of people forced to flee conflict, violence, human rights violations, and persecution has now crossed the staggering milestone of 100 million for the first time on record, highlighting worldwide food insecurity, the climate crisis, war in Ukraine and other emergencies from Africa to Afghanistan as leading causes.

Ann Moey, Partnerships Manager at UNHCR says, “International solidarity is needed now more than ever, and all sectors of society can do their bit to help. Support from private sector partners like Vantage helps us inject vital energy into our humanitarian efforts, and allows us to deliver more assistance to vulnerable, displaced communities worldwide.”

The fundraising initiative is another step forward in Vantage’s corporate ESG journey, which was driven by the collective desire among its staff to make the world a better place. This donation drive follows closely after Vantage’s partnership with Supercar Blondie in participating in the Blue Carbon ESG initiative in Sardinia, Italy, as well as its multi-year sponsorship of the McLaren MX Extreme E team.

Sofiia Starchevska, ESG Ambassador at Vantage, said, “It’s infinitely more empowering and motivating knowing that your actions are one of many. It’s easier to see the power of collective, as opposed to individual, action, and this is what we want to achieve with this fundraising activity.”

“At Vantage, we know that the mental, emotional, and physical trauma of being displaced and having to rebuild in a strange land is a massive challenge, and we hope our initiative will double our support for refugees to seek protection and enable them to rebuild their lives. Together with UNHCR, we hope to make care our shared currency.”

For more information about our fundraising programme, please visit: https://donate.unhcr.org/sg/en-sg/vantage

About Vantage

Vantage is a global, multi-asset broker offering clients access to a nimble and powerful service for trading CFDs on Forex, Commodities, Indices, and Shares.

With more than 10 years of market experience. Vantage now has over 1,000 employees/personnel across more than 30 global offices.

Vantage is more than a broker. It provides a trusted trading ecosystem, an award-winning mobile trading app, and a faster and simpler trading platform that enables clients to take advantage of trading opportunities. Download the Vantage App on App Store or Google Play.

Be empowered to better capitalise on winning market opportunities when you
trade smarter @vantage.

Photo – https://mma.prnewswire.com/media/1869033/UNHCR_PR_Imagery.jpg
Logo – https://mma.prnewswire.com/media/1745281/Vantage_Logo.jpg

‫تشارك Vantage المفوضية السامية للأمم المتحدة لشؤون اللاجئين في نشاط عالمي لجمع التبرعات للاجئين، وتتطابق مع التبرعات بالدولار مقابل الدولار.

سنغافورة, 1 أغسطس 2022 /PRNewswire/ — يسر شركةVantage، وهي شركة وساطة دولية متعددة الأصول، أن تعلن أنها ستطلق حملة تبرعات لمدة شهر لدعم المفوضية السامية للأمم المتحدة لشؤون اللاجئين لمساعدة اللاجئين والنازحين داخليًا في جميع أنحاء العالم.

Vantage partners UNHCR for global fundraising activity for refugees, matches donations dollar-for-dollar.

ستقوم Vantage بمطابقة جميع التبرعات المقدمة من العملاء الجدد والحاليين على حد سواء، بالدولار مقابل الدولار، لدعم الجهود الإنسانية التي تقوم بها  UNHCR . ستستمر حملة التبرع لمدة شهر واحد حتى 30 أغسطس ويمكن تمديدها بناء على آراء العملاء.

 المفوضية هي منظمة عالمية أمضت السنوات الـ 70 الماضية مكرسة لإنقاذ الأرواح وحماية الحقوق وبناء مستقبل أفضل للاجئين. تعتقد Vantage والمفوضية معًا أن لكل شخص الحق في طلب اللجوء والعثور على ملجأ آمن.

ووفقًا للمفوضية، تجاوز عدد الأشخاص الذين أجبروا على الفرار من الصراع والعنف وانتهاكات حقوق الإنسان والاضطهاد الآن معلمًا مذهلًا بلغ 100 مليون شخص لأول مرة على الإطلاق، مما يسلط الضوء على انعدام الأمن الغذائي في جميع أنحاء العالم، وأزمة المناخ، والحرب في أوكرانيا، وغيرها من حالات الطوارئ من أفريقيا إلى أفغانستان كأسباب رئيسية.

تقول آن موي، مديرة الشراكات في المفوضية: “هناك حاجة إلى التضامن الدولي الآن أكثر من أي وقت مضى، ويمكن لجميع قطاعات المجتمع القيام بواجبها للمساعدة. ويساعدنا الدعم المقدم من شركاء القطاع الخاص مثل Vantage على ضخ طاقة حيوية في جهودنا الإنسانية، ويسمح لنا بتقديم المزيد من المساعدات للمجتمعات الضعيفة والنازحة في جميع أنحاء العالم.”

وتعد مبادرة جمع التبرعات خطوة أخرى إلى الأمام في   رحلة الحوكمة البيئية والاجتماعية وحوكمة الشركات في Vantage ، والتي كانت مدفوعة بالرغبة الجماعية بين موظفيها لجعل العالم مكانًا أفضل. وتأتي حملة التبرعات هذه بعد شراكة Vantage مع  Supercar Blondie  المشاركة في مبادرة Blue Carbon ESG في سردينيا، إيطاليا، فضلًا عن رعايتها المتعددة السنوات  وفريق ماكلارين MX Extreme E .

وقالت صوفيا ستارشيفسكا، سفيرة الحوكمة البيئية والاجتماعية وحوكمة الشركات في Vantage ، إنه أمر أكثر تمكينًا وتحفيزًا بلا حدود مع العلم أن إجراءاتك هي واحدة من العديد من الإجراءات. من الأسهل رؤية قوة العمل الجماعي، بدلًا من العمل الفردي، وهذا ما نريد تحقيقه من خلال نشاط جمع التبرعات هذا.”

“في Vantage ، نعلم أن الصدمة العقلية والعاطفية والجسدية للنزوح والاضطرار إلى إعادة البناء في أرض غريبة تمثل تحديًا هائلًا، ونأمل أن تضاعف مبادرتنا دعمنا للاجئين لطلب الحماية وتمكينهم من إعادة بناء حياتهم. وبالتعاون مع المفوضية، نأمل أن نجعل الرعاية عملتنا المشتركة.”

لمزيد من المعلومات حول برنامج جمع التبرعات لدينا، يرجى زيارة:
https://donate.unhcr.org/sg/en-sg/vantage

نبذة عن Vantage

Vantage هي وسيط عالمي متعدد الأصول يوفر للعملاء الوصول إلى خدمة ذكية وقوية لتداول العقود مقابل الفروقات في الفوركس والسلع والمؤشرات والأسهم.

إلى جانب التمتع بخبرة في السوق أكثر من 10 سنوات. يعمل لدى Vantage حاليًا أكثر من 1,000 موظفًا في أكثر من 30 مكتبًا حول العالم.

Vantage هي أكثر من مجرد وسيط. إنها توفر نظامًا بيئيًا للتداول موثوقًا،  تطبيق تداول للجوّال الحائز على الجوائز ، ومنصة تداول أسرع وأبسط تمكن العملاء من الاستفادة من فرص التداول. قم بتنزيل  تطبيق Vantage App  على App Store أو Google Play .

كن قادرًا على الاستفادة بشكل أفضل من فرص السوق الرابحة عندما 

تتداول بذكاء في Vantage .

 الصورة –  https://mma.prnewswire.com/media/1869033/UNHCR_PR_Imagery.jpg

رابط الشعار –  https://mma.prnewswire.com/media/1745281/Vantage_Logo.jpg  

AOP Health Starts Research for Leukemia Treatment

AOP Health signed an agreement with Leukos Biotech for the further development of a newly discovered chemical substance. With this agreement AOP Health expands the hemato-oncology research area even further and provides additional treatment options for certain leukemia patients in the longer term.

Agnes Kohl, Chief Business Officer, AOP Orphan Pharmaceuticals GmbH, Member of the AOP Health Group

Photo credit: Studio Koekart: Natascha Unkart & Isabelle Köhler

VIENNA, Austria, Aug. 01, 2022 (GLOBE NEWSWIRE) — The AOP Health Group (AOP Health) is a European pioneer for integrated therapies for rare diseases and in critical care headquartered in Vienna, Austria. The company focuses on research, development and global sales of innovative treatment solutions and specializes in therapies for rare diseases and intensive care. In early July, AOP Health signed an agreement with Leukos Biotech, a spin-off company founded by the Barcelona-based Josep Carreras Leukaemia Research Institute. The agreement signed by AOP Health covers the option for developments of the newly discovered chemical substance within any treatable indication, not limited to oncological or rare diseases.

Luis Ruiz-Avila, Chief Executive Officer Leukos Biotech

Copyright: Albert Mollon

Agreement sets basis for new areas of therapy

At first, AOP Health will focus on the development of treatment options for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS). Both are special disease types of leukemia that often start in the bone marrow. Agnes Kohl, Chief Business Officer of AOP Orphan Pharmaceuticals GmbH, Member of the AOP Health Group explains: “Based on positive data, our plan is to expand the development for further orphan indications even outside of AML and MDS at a later stage. With this agreement, we may be able to broaden the portfolio within our therapeutic areas offering even more treatment options for patients.”

Development in cooperation with Leukos

As AOP Health focuses on rare, hemato-oncological cancers and has many years of experience in the development and commercialization of hemato-oncological treatments, the company will drive the further development of the substance in cooperation with Leukos based on a new mode of action. This could potentially turn into a milestone in the treatment of many blood cancer and other cancer patients. Luis Ruiz-Avila, Chief Executive Officer of Leukos Biotech: “We focus on developing new treatments for a wide variety of tumors. We were born to transform excellent science from the Josep Carreras Leukaemia Research Institute into valuable products for cancer patients in need, and this agreement is a very significant step in that direction. We are convinced that AOP Health is the right partner to turn this promising, novel mechanism of action into a clinical reality for the benefit of patients in a wide variety of unmet medical needs”.

About AOP Health

The AOP Health Group incorporates several companies including AOP Orphan Pharmaceuticals GmbH with its seat in Vienna, Austria (“AOP Health”). The AOP Health Group is the European pioneer for integrated therapies for rare diseases and in critical care. Over the past 25 years, the Group has become an established provider of integrated therapy solutions operating from its headquarters in Vienna, its subsidiaries and representative offices throughout Europe and the Middle East, as well as through partners worldwide. This development has been made possible by a continually high level of investment in research and development on the one hand and a highly consistent and pragmatic orientation towards the needs of all its stakeholders on the other – especially the patients and their families as well as also the healthcare professionals treating them.

About Leukos

Leukos Biotech, SL (Leukos) is a spin-off company from the Josep Carreras Leukaemia Research Institute incorporated in Barcelona in 2015. The company is developing new treatments and diagnostic tools for a wide variety of tumors targeting the serotonin receptor HTR1B, which antitumoral potential was first described and patented by Leukos’ founder Dr. Ruth Risueño in her laboratory at the Josep Carreras Research Institute. Leukos’ main financial support is from private and institutional investors. The main shareholders are Inveready, CDTI Innvierte and the Josep Carreras Foundation. Besides investors’ support, Leukos has received non-dilutive grants and loans from the Catalan Government, the Spanish Government and the European Union in various programs.

About the Josep Carreras Foundation

The Josep Carreras Leukaemia Foundation was established in 1988 with the intention of contributing to finding a definitive cure for this disease. Its efforts are concentrated on four basic areas: administering the Spanish Bone Marrow Donor Registry (REDMO), scientific research, carried out by the Josep Carreras Leukaemia Research Institute, patient guidance through an online patient consultation channel, and reception apartments for patients who need to undergo treatment and have to spend a long time far from home.

About the Josep Carreras Leukaemia Research Institute

The Josep Carreras Leukaemia Research Institute, a public centre pertaining to the Generalitat de Catalunya’s CERCA network, was established in 2010 with the aim of furthering biomedical research and personalised medicine in the field of leukaemia and other onco-hematological diseases. It is the first research centre in Europe exclusively focussed on leukaemia and malignant blood diseases, and one of the very few in the world. The Josep Carreras Institutes has three coordinated but independent scientific campuses: University of Barcelona Hospital Clínic Campus, The Catalan Institute of Oncology/Germans Trias i Pujol Campus, and the Sant Pau – Autonomous University of Barcelona (UAB) Campus

About Inveready

Inveready is a leading alternative asset manager in Spain – investing in early-stage VC, growth VC, venture debt, strategic equity in listed companies, infrastructure and private equity – providing financing solutions to companies throughout their life-cycle. Founded in 2008, Inveready counts on 200 active companies, and more than €1bn of assets under management. Inveready has been investing in companies in the Life Sciences sector since 2008. Notable investments in this vertical are Atrys Health (listed on the Spanish market), EDESA Biotech (listed on Nasdaq), AVX Pharma (sold to Aerie Biotech) and PaloBiofarma (licensing agreement with Novartis). Inveready is headquartered in San Sebastian, and has other offices in Barcelona and Madrid. It has been recognized on multiple occasions by ASCRI and Preqin for the return on its funds and transactions (For more information, visit www.inveready.com).

Mag Nina Roth, MAS
nina.roth@aop-health.com

AOP Health
Needs. Science. Trust.

AOP Orphan Pharmaceuticals GmbH
Member of the AOP Health Group

Leopold-Ungar-Platz 2, 1190 Vienna, Austria
aop-health.com

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/f096650f-dbfc-4165-854b-63345d24a713

https://www.globenewswire.com/NewsRoom/AttachmentNg/9aa481fe-91da-4609-8570-2e9a1012c392